Gennex Lab.

{
  "main_header": {
    "sid": 930938,
    "name": "Gennex Lab.",
    "stock_name": "Gennex Lab.",
    "full_name": "Gennex Laboratories Ltd",
    "name_url": "stocks-analysis/gennex-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "12.44",
    "chg": -0.11,
    "chgp": "-0.88%",
    "dir": -1,
    "prev_price": "12.55",
    "mcapval": "307.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531739,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE509C01026",
    "curr_date": "Feb 11",
    "curr_time": "",
    "bse_nse_vol": "1.0 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 11, 2026",
    "traded_date_str": "2026 02 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gennex-lab-930938-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Gennex Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-gennex-laboratories-ltd-3825245",
        "imagepath": "",
        "date": "2026-02-06 23:18:46",
        "description": "The next results date for Gennex Laboratories Ltd is scheduled for 14 February 2026...."
      },
      {
        "title": "Gennex Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-is-rated-sell-3816323",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GennexLaborator_mojoScore_3816323.png",
        "date": "2026-02-02 10:10:04",
        "description": "Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Gennex Laboratories Ltd Downgraded to Sell Amid Technical Weakness and Financial Setbacks",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-downgraded-to-sell-amid-technical-weakness-and-financial-setbacks-3795498",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GennexLaborator_mojoScore_3795498.png",
        "date": "2026-01-20 08:26:48",
        "description": "Gennex Laboratories Ltd has seen its investment rating downgraded from Hold to Sell, reflecting deteriorating technical indicators and disappointing financial performance. Despite a strong long-term growth record, recent quarterly results and bearish technical signals have prompted a reassessment of the stock’s outlook, signalling caution for investors amid underperformance relative to the broader market."
      },
      {
        "title": "Gennex Laboratories Ltd Downgraded to Sell Amid Technical and Financial Weakness",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-downgraded-to-sell-amid-technical-and-financial-weakness-3782756",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GennexLaborator_mojoScore_3782756.png",
        "date": "2026-01-06 08:44:30",
        "description": "Gennex Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 5 January 2026. This shift reflects a combination of deteriorating technical indicators, subdued financial performance, and valuation concerns, signalling caution for investors amid a challenging market environment."
      },
      {
        "title": "Gennex Laboratories Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-upgraded-to-hold-as-technicals-improve-amid-mixed-financials-3775816",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GennexLaborator_mojoScore_3775816.png",
        "date": "2025-12-31 08:14:18",
        "description": "Gennex Laboratories Ltd has seen its investment rating upgraded from Sell to Hold as of 30 December 2025, driven primarily by a shift in technical indicators and a more attractive valuation profile. Despite recent financial setbacks, the company’s long-term growth prospects and improving market sentiment have contributed to this reassessment."
      },
      {
        "title": "Gennex Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-is-rated-sell-3771936",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GennexLaborator_mojoScore_3771936.png",
        "date": "2025-12-27 10:10:04",
        "description": "Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 December 2025, providing investors with an up-to-date view of the company's performance and outlook."
      },
      {
        "title": "Gennex Laboratories Faces Revised Market Assessment Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-downgraded-to-sell-amid-weak-financials-and-technical-signals-3759685",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GennexLaborator_mojoScore_3759685.png",
        "date": "2025-12-16 08:41:22",
        "description": "Gennex Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has experienced a shift in market evaluation following a detailed reassessment of its financial performance, valuation, technical indicators, and overall quality metrics. This article explores the factors influencing the recent changes in the company’s market standing and what investors should consider in light of these developments."
      },
      {
        "title": "Gennex Lab. Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-lab-upgraded-from-sell-to-hold-by-marketsmojo-on-12-nov-2025-3741157",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GennexLab_mojoScore_3741157.png",
        "date": "2025-12-02 10:09:33",
        "description": "Gennex Lab., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting nuanced shifts across key analytical parameters. This adjustment follows a period marked by contrasting financial trends and valuation metrics, prompting a reassessment of the company’s standing within its sector and relative to market benchmarks."
      },
      {
        "title": "Why is Gennex Lab. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-gennex-lab-fallingrising-3722166",
        "imagepath": "",
        "date": "2025-11-22 01:12:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>Gennex Laboratories has experienced a significant correction over the past week, with its stock price declining by 12.88%, in stark contrast to the Sensex’s modest gain of 0.79% during the same period. This divergence highlights the stock’s relative weakness amid a generally stable market environment. Over the last month, the stock has also lagged, posting a 3.58% loss while the Sensex advanced by 0.95%. Year-to-date figures further underline this underperformance, with Gennex down 15.97% compared to the Sensex’s 9.08% gain. The one-year performance gap is even more pronounced, with the stock falling 27.58% while the benchmark rose 10.47%.</p>\n<p>Despite these recent setbacks, it is important to note that Gennex Laboratories has del..."
      }
    ],
    "total": 138,
    "sid": "930938",
    "stock_news_url": "https://www.marketsmojo.com/news/gennex-laboratories-930938"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "09-Feb-2026",
      "details": "Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper publication regarding Meeting of Board of Directors of the Company scheduled to be held on Saturday February 14 2026 for adoption of Unaudited (Standalone & Consolidated) Financial Results for the Quarter and Nine months ended December 31 2025 along with the Limited Review Report of the Statutory Auditors of the company. Notice had been published in both Business Standard and Saksham (Local-Telugu) on February 07 2026. We request you to take the above information on record and acknowledge receipt of the same.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2025",
      "datetime": "05-Feb-2026",
      "details": "Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve 1. Consider and adopt the Unaudited Financial Statements (Standalone and Consolidated) for the Quarter and Nine Months ended December 31 2025; 2. Consider the Limited Review Reports of the Statutory Auditor on Standalone and Consolidated Financial Statements for the Quarter and Nine Months ended December 31 2025; 3. Other Business items.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "12-Jan-2026",
      "details": "With reference to the captioned subject matter pursuant to Regulation 74(5) of SEBI (DP) Regulations 2018 we hereby submit the Certificate received from the M/s. R&D Infotech Private Limited Registrar and Transfer Agent of the Company for the quarter ended December 31 2025. We request you to take the above information on record and acknowledge receipt of the same.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "14 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Gennex Laboratories Ltd has announced <strong>1:10</strong> stock split, ex-date: 14 Dec 09",
          "dt": "2009-12-14",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Gennex Laboratories Ltd has announced <strong>1:2</strong> rights issue, ex-date: 21 Jul 22",
          "dt": "2022-07-21",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

When is the next results date for Gennex Laboratories Ltd?

2026-02-06 23:18:46

The next results date for Gennex Laboratories Ltd is scheduled for 14 February 2026....

Read full news article

Gennex Laboratories Ltd is Rated Sell

2026-02-02 10:10:04

Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Gennex Laboratories Ltd Downgraded to Sell Amid Technical Weakness and Financial Setbacks

2026-01-20 08:26:48

Gennex Laboratories Ltd has seen its investment rating downgraded from Hold to Sell, reflecting deteriorating technical indicators and disappointing financial performance. Despite a strong long-term growth record, recent quarterly results and bearish technical signals have prompted a reassessment of the stock’s outlook, signalling caution for investors amid underperformance relative to the broader market.

Read full news article

Gennex Laboratories Ltd Downgraded to Sell Amid Technical and Financial Weakness

2026-01-06 08:44:30

Gennex Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 5 January 2026. This shift reflects a combination of deteriorating technical indicators, subdued financial performance, and valuation concerns, signalling caution for investors amid a challenging market environment.

Read full news article

Gennex Laboratories Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials

2025-12-31 08:14:18

Gennex Laboratories Ltd has seen its investment rating upgraded from Sell to Hold as of 30 December 2025, driven primarily by a shift in technical indicators and a more attractive valuation profile. Despite recent financial setbacks, the company’s long-term growth prospects and improving market sentiment have contributed to this reassessment.

Read full news article

Gennex Laboratories Ltd is Rated Sell

2025-12-27 10:10:04

Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 December 2025, providing investors with an up-to-date view of the company's performance and outlook.

Read full news article

Gennex Laboratories Faces Revised Market Assessment Amid Mixed Financial and Technical Signals

2025-12-16 08:41:22

Gennex Laboratories, a player in the Pharmaceuticals & Biotechnology sector, has experienced a shift in market evaluation following a detailed reassessment of its financial performance, valuation, technical indicators, and overall quality metrics. This article explores the factors influencing the recent changes in the company’s market standing and what investors should consider in light of these developments.

Read full news article

Gennex Lab. Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-12-02 10:09:33

Gennex Lab., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting nuanced shifts across key analytical parameters. This adjustment follows a period marked by contrasting financial trends and valuation metrics, prompting a reassessment of the company’s standing within its sector and relative to market benchmarks.

Read full news article

Why is Gennex Lab. falling/rising?

2025-11-22 01:12:08

Recent Price Movement and Market Comparison

Gennex Laboratories has experienced a significant correction over the past week, with its stock price declining by 12.88%, in stark contrast to the Sensex’s modest gain of 0.79% during the same period. This divergence highlights the stock’s relative weakness amid a generally stable market environment. Over the last month, the stock has also lagged, posting a 3.58% loss while the Sensex advanced by 0.95%. Year-to-date figures further underline this underperformance, with Gennex down 15.97% compared to the Sensex’s 9.08% gain. The one-year performance gap is even more pronounced, with the stock falling 27.58% while the benchmark rose 10.47%.

Despite these recent setbacks, it is important to note that Gennex Laboratories has del...

Read full news article

View All News